Tag: Motley Fool

  • Why Afterpay, IOOF, Redbubble, & Zip shares are dropping lower

    graph of paper plane trending down

    In late morning trade the S&P/ASX 200 Index (ASX: XJO) is back on form and is charging notably higher. At the time of writing the benchmark index is up 1.45% to 6,040.1 points.

    Four shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:

    The Afterpay Ltd (ASX: APT) share price is down 4% to $80.84. Investors have been selling the payments company’s shares again on Wednesday following an announcement by PayPal yesterday. That announcement revealed the upcoming launch of Pay in 4 in the United States. As its names indicates, Pay in 4 is a buy now pay later offering which allows consumers to pay for items in four interest-free instalments.

    The IOOF Holdings Limited (ASX: IFL) share price has crashed 21% lower to $3.66. This follows the completion of the institutional component of its $1,040 million capital raising. IOOF raised a total of $734 million from institutional investors at a 24.4% discount of $3.50. It launched the capital raising to partly fund the acquisition of the National Australia Bank Ltd (ASX: NAB) wealth business, MLC Wealth for $1,440 million.

    The Redbubble Ltd (ASX: RBL) share price is down 3.5% to $4.04. This appears to be down to profit taking from investors after some stellar gains in recent weeks. In fact, on Tuesday the Redbubble share price jumped to a record high despite the market selloff. One broker that believes its shares can still go higher is Morgans. It recently put a $4.33 price target on the company’s shares.

    The Zip Co Ltd (ASX: Z1P) share price has crashed 14% lower to $6.89. Investors have been selling the buy now pay later provider’s shares amid concerns that the PayPal launch could undermine its US ambitions. Zip isn’t in as strong a position as Afterpay to fend off PayPal in the lucrative market. In addition to this, this morning Citi downgraded its shares to a sell rating with a $6.70 price target.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why Afterpay, IOOF, Redbubble, & Zip shares are dropping lower appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2EWlkVr

  • Why the IOOF share price is crashing 21% lower today

    red arrow pointing down and smashing through ground

    The worst performer on the S&P/ASX 200 Index (ASX: XJO) on Wednesday has been the IOOF Holdings Limited (ASX: IFL) share price by some distance.

    In morning trade the financial services company’s shares have crashed 21% lower to $3.64.

    Why is the IOOF share price crashing lower?

    Investors have been selling IOOF’s shares on Wednesday after they returned from a trading halt following the completion of the institutional component of its capital raising.

    According to the release, the fully underwritten institutional placement and the institutional component of its entitlement offer raised a total of approximately $734 million. This comprised $452 million from its placement and $282 million from its entitlement offer.

    Management revealed that the placement attracted significant demand from new and existing institutional investors. It was a similar story for the entitlement offer, with a take-up rate by eligible institutional shareholders of over 92%.

    These funds were raised at $3.50 per new share, which represents a discount of 24.4% to its last close price.

    IOOF will now push ahead with its underwritten retail entitlement offer, which aims to raise a further $306 million, and its share purchase plan aiming to raise $50 million.

    Why is IOOF raising funds?

    IOOF launched its capital raising to partly fund the acquisition of the National Australia Bank Ltd (ASX: NAB) wealth business, MLC Wealth for $1,440 million. It also expects the funds to provide greater financial flexibly to continue to execute its growth strategy.

    IOOF’s CEO, Renato Mota, was pleased with the success of its placement and entitlement offer.

    He said: “We are encouraged by the strong vote of confidence from institutional investors as we take this once in a generation opportunity to create the leading wealth manager of the future.”

    “We are also pleased that investors recognise that the strategic and value propositions are compelling. However, as CEO and as a company, we understand the obligations that attach to this. We will be entirely focused on delivering the promised better outcomes for all our stakeholders; our clients, members, advisers, the community and our shareholders,” he added.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the IOOF share price is crashing 21% lower today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3jyFL9O

  • 3 ASX shares to buy for international growth

    ASX

    I believe that international growth is a key part of delivering strong returns for ASX shares.

    Australia is a great country, but it only has a small population. It’s a good place to start, but businesses with global exposure have much larger growth potential due to the bigger total addressable market.

    You can get that exposure either through ASX growth shares with international earnings like CSL Limited (ASX: CSL), or you can go for an investment product that offers that international growth potential.

    Here are some great ideas:

    A2 Milk Company Ltd (ASX: A2M)

    A2 Milk could be one of the best ASX growth shares for international growth. The A2 Milk share price has fallen since the FY20 result. It’s down 14% since the start of August. I think it’s a good time to buy shares.

    China and the USA are two big growth markets for the company.

    Total A2 Milk revenue rose by 32.8% to NZ$1.73 billion in FY20. But Chinese label infant nutrition revenue more than doubled to NZ$337.7 million with store distribution growing to 19,100 stores. USA milk revenue growth rose 91.2% to NZ$66.1 million and the distribution grew to 20,300 stores – up from 13,100 at the end of FY19.

    In FY21 the company is expecting continued strong revenue growth with a solid earnings before interest, tax, depreciation and amortisation (EBITDA) margin of 30% to 31%.

    I think this ASX share is one to watch. At the pre-open A2 Milk share price it’s trading at 26x FY22’s estimated earnings.

    Magellan High Conviction Trust (ASX: MHH)

    One of the best ways to get exposure to international growth could be to go for a quality listed investment trust (LIT) or company (LIC).

    Magellan High Conviction Trust is a LIT that targets the best businesses in the world. A group of great companies can just keep winning year after year. The ASX share owns stocks like Alibaba, Alphabet, Microsoft, Tencent and Facebook. These are really good technology businesses that are constantly looking for ways to grow and diversify earnings.

    Technology businesses are also some of the least affected by COVID-19 impacts because their service is provided digitally. Indeed, a business like Microsoft has seen a huge shift to its cloud infrastructure – bringing forward a lot of demand.

    The stronger Australian dollar makes it better value to buy international shares. At the pre-open Magellan High Conviction Trust share price, the ASX share is trading at a 5.5% discount to the indicative net asset value (NAV).

    PM Capital Global Opportunities Fund Ltd (ASX: PGF)

    PM Capital is a well-respected fund manager which runs this LIC that looks for good value businesses when they’re unloved by the market.

    Some of the businesses that it owns include names like Cairn Homes, Bank of America, Visa, MGM China Holdings, KKR & Co, Siemens and Freeport-McMoRan.

    I think that some of the cyclical businesses it’s invested in could rebound nicely over the next few years as the global economy comes out of COVID-19.

    The ASX share recently launched an off-market equal access buyback to boost the share price. It also grew its dividend in the recent FY20 result. It currently offers a grossed-up dividend yield of 6.4%, which I think is good in this low interest environment.

    At the current PM Capital Global Opportunities Fund share price it’s still valued at a 15% discount to the pre-tax net tangible assets (NTA) per share at 28 August 2020.

    Foolish takeaway

    I really like all three of these ASX shares for the international growth exposure. At the current price I think A2 Milk is too good to pass up considering it continues to grow at an impressive rate with more growth ahead as it expands its distribution network. However, both of the investment businesses look good value today too.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Tristan Harrison owns shares of PM Capital Global Opportunities Fund Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX shares to buy for international growth appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/34WuxrE

  • Mesoblast share price flat on Australian phase 3 COVID-19 trial news

    The Mesoblast limited (ASX: MSB) share price is trading flat on Wednesday despite the release of a positive announcement.

    In morning trade the allogeneic cellular medicines company’s shares are changing hands for $5.24.

    What did Mesoblast announce?

    This morning Mesoblast announced that it has received ethics approval to include Australian hospitals in the Phase 3 randomised controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with acute respiratory distress syndrome (ARDS).

    According to the release, participating hospitals in Melbourne and Sydney have been granted approval by the Human Research Ethics Committee of Monash Health and will join more than 17 leading US medical centres that are already part of the Phase 3 trial.

    This study is being conducted by the US National Institutes of Health–funded Cardiothoracic Surgical Trials Network, and cleared by the US Food and Drug Administration (FDA).

    Mesoblast’s Chief Executive, Dr Silviu Itescu, appeared to be pleased with the news.

    He stated: “As an Australian company developing a potential treatment for COVID-19 ARDS, the primary cause of death in patients infected with COVID-19, we have a responsibility to evaluate remestemcel-L in Australian patients as the country continues to grapple with COVID-19.”

    What does the trial consist of?

    Mesoblast’s phase 3 trial is enrolling ventilator-dependent patients in intensive care units with moderate to severe COVID-19 ARDS. They are randomised (1:1) to receive either two intravenous infusions of remestemcel-L three to five days apart or a placebo on top of maximal care.

    The primary endpoint is all-cause mortality within 30 days of randomisation, with the key secondary endpoint being the number of days off mechanical ventilator support.

    The trial’s independent Data Safety Monitoring Board plans to complete an interim analysis this month in the trial’s first 90 patients randomised in the United States after they have completed 30 days of follow up.

    After the review of the safety and efficacy data, the Data Safety Monitoring Board will provide a recommendation to Mesoblast on whether the trial should proceed as planned or stop early.

    That data should be released later this month and will be worth watching out for.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Mesoblast share price flat on Australian phase 3 COVID-19 trial news appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/32QY6YU

  • Market crash 2020: 3 stock warning signs to watch out for

    three yellow exclamation marks on blue background

    The 2020 stock market crash may have caused some investors to turn to other assets that are less risky than shares. However, buying stocks today could prove to be a sound long-term move that delivers relatively high returns.

    Of course, an uncertain economic outlook means that avoiding companies with weak balance sheets, high valuations and business models that may not easily adapt to change could be a shrewd move. It may reduce your risks and help to improve your return prospects.

    High valuations after the market crash

    Even though the stock market crash occurred only a handful of months ago, some shares now appear to be trading on excessive valuations. Certainly, they could move higher in the short run if investor sentiment continues to improve as per recent trends. However, buying any asset for more than it is worth could prove to be a means of generating poor returns over the long run.

    Therefore, it may be prudent to focus your capital on stocks that have more attractive valuations based on their financial position and outlooks. The prospects for the world economy continue to be very uncertain, with risks such as coronavirus and Brexit having the potential to cause a second downturn for stock prices in the near term. By investing in undervalued, rather than overvalued, stocks you can limit your potential losses in the short run and benefit from greater capital return prospects in the long term.

    Weak balance sheets

    The uncertain economic outlook following the market crash means that companies with weak balance sheets may struggle to survive. For example, they may have high debt levels or lack access to liquidity. Should their sales come under pressure, they may struggle to remain afloat compared to sector peers that have modest debt levels and stronger cash flow.

    Therefore, it could be a good idea to hold companies with sound financial positions. Investors can determine the financial strength of a business through looking at its annual report and recent market updates. This information is available freely online, and could help you to avoid weak businesses that ultimately prove to be disappointing investment opportunities in the current challenging economic climate.

    An inability to evolve

    Following the market crash, some sectors may need to evolve rapidly to respond to changing consumer tastes. The coronavirus pandemic may have fundamentally changed sectors such as energy, banking and retail forever. Businesses that can adapt their operations to accommodate different consumer tastes may therefore have a competitive advantage over their peers.

    As such, avoiding companies that lack the right strategy to evolve their business models could be a sound move. Clearly, assessing this factor is highly subjective. However, by considering the strategies of a company compared to its sector peers, it may be possible to purchase those stocks with the financial capacity to make necessary changes to their business models so they can return to strong growth in the long run.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Market crash 2020: 3 stock warning signs to watch out for appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3lCToXj

  • Brainchip share price rockets 30% higher on NASA program collaboration

    Rocket launching into space

    The Brainchip Holdings Ltd (ASX: BRN) share price has been on fire again on Wednesday morning.

    At the time of writing the artificial intelligence technology company’s shares are up 30% to a 52-week high of 40.5 cents.

    Why is the Brainchip share price rocketing higher?

    Investors have been scrambling to buy Brainchip’s shares this morning after it announced a collaboration with VORAGO Technologies.

    VORAGO Technologies is a privately held, high technology company based in Texas with over 15 years of experience in providing radiation-hardened and extreme-temperature solutions for the Hi-reliability marketplace.

    According to the release, it is recognised as one of Inc 5000’s Fastest Growing Private Companies in America.

    VORAGO’s patented HARDSIL technology uses cost-effective high-volume manufacturing to harden any commercially designed semiconductor component for extreme environment operation. It has created a number of solutions throughout Aerospace, Defense, and Industrial applications.

    What is the collaboration?

    Management advised that the collaboration is intended to support a Phase I NASA program for a neuromorphic processor that meets spaceflight requirements.

    The agreement includes payments that are intended to offset the its expenses to support partner needs.

    BrainChip’s CEO, Louis DiNardo, commented: “We are both excited and proud to participate in this Phase I program with VORAGO Technologies and support NASA’s desire to leverage neuromorphic computing in spaceflight applications. The combination of benefits from the Akida neuromorphic processor and a radiation-hardened process brings significant new capabilities to spaceflight and aerospace applications.”

    The company notes that its Akida neuromorphic processor is uniquely suited for spaceflight and aerospace applications. The device is a complete neural processor and does not require an external CPU, memory or Deep Learning Accelerator.

    This is important as reducing component count, size, and power consumption are paramount concerns in spaceflight and aerospace applications.

    Bernd Lienhard, VORAGO CEO, commented: “We are thrilled and honored to partner with BrainChip to harness the radiation hardening capabilities of our patented HARDSIL technology for the Phase I program with NASA. Our ongoing mission of creating components with increased availability and unmatched solutions in aerospace and defense applications paired with the Akida neuromorphic processor will create unprecedented standards moving forward in the industry.”

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Brainchip share price rockets 30% higher on NASA program collaboration appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31PRVoY

  • Xero share price higher after chairman buys $400k worth of shares

    finger pressing red button on keyboard labelled Buy

    The Xero Limited (ASX: XRO) share price is pushing higher on Wednesday morning.

    At the time of writing the cloud-based business and accounting software company’s shares are up slightly to $100.00.

    Why is the Xero share price pushing higher?

    Xero’s shares were given a lift this morning from some insider buying news.

    According to a change of director’s interests notice, the company’s chairman, David Thodey AO, has been buying shares this week.

    The notice reveals that Mr Thodey picked up 4,000 Xero shares through an on-market trade on Monday. The chairman paid an average of $101.34 per share, which equates to a total consideration of $405,357.41.

    This purchase lifted Mr Thodey’s holding in the company to a total of 8,461 shares.

    Should you invest?

    Just as insider selling is a bearish indicator, insider buying is often seen as a bullish indicator. After all, who knows a company better than its own directors.

    I already felt that Xero was a buy, but this significant insider buying gives me extra confidence in this view.

    Overall, I believe Xero is one of the best buy and hold options on the Australian share market.

    This is due to its high quality platform, which was recently strengthened with the acquisition of Waddle, favourable industry tailwinds, and its massive global market opportunity.

    In respect to the latter, I believe the company has a significant opportunity in the North American market. At the end of FY 2020, Xero had just 241,000 subscribers in this lucrative market. This compares to a sizeable 914,000 subscribers in a materially smaller ANZ market.

    If it can make a success of its expansion in North America, which I believe it will, then it should underpin very strong subscriber and recurring revenue growth over the next decade and beyond.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Xero share price higher after chairman buys $400k worth of shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3jCrQQ5

  • Nufarm share price charges higher on FY 2020 guidance

    shares higher, growth shares

    The Nufarm Limited (ASX: NUF) share price is charging higher in morning trade.

    At the time of writing the agricultural chemical company’s shares are up 4% to $4.07.

    What did Nufarm announce?

    This morning Nufarm announced a non-cash asset impairment and revealed its unaudited FY 2020 earnings estimate.

    According to the release, the company expects to recognise non-cash, impairment charges in relation to its European assets of approximately $215 million in FY 2020.

    This comprises a pre-tax impairment of intangible assets of approximately $190 million and a derecognition of tax assets of approximately $25 million.

    Management advised that the assessment of the carrying value takes into account recent operating performance and a moderated outlook of future earnings. The latter is based on an expectation of continuing margin pressure in its base product portfolio due to higher manufacturing costs and increased competition.

    And while there are early indications that raw material costs for products in the portfolios Nufarm acquired in 2018 are easing, it notes that input costs for a small number of products are expected to remain elevated in the medium term. This has also been reflected in the carrying value assessment.

    While this is disappointing, Nufarm’s CEO, Greg Hunt, appears confident it is onwards and upwards from here for the European business.

    He commented: “We believe the European business has reached an earnings trough in FY20, however it is appropriate to take this step to revise the carrying value of the assets. We have a comprehensive improvement program underway in Europe to grow revenues, reduce our cost to serve and lift margins.”

    “We expect this program, combined with an anticipated easing in raw material costs and improved weather conditions would be the major drivers of improved profitability in the European business in FY21,” he concluded.

    FY 2020 earnings estimates.

    Based on its preliminary and unaudited accounts, Nufarm expects underlying group earnings before interest, tax, depreciation and amortisation (EBITDA) to be in the range of $290 million to $300 million in FY 2020.

    Though, following the sale of the South American businesses, underlying EBITDA from continuing operations is expected to be in the range of $230 million to $240 million. This compares to EBITDA of $420 million in FY 2019.

    Mr Hunt commented: “We have delivered positive momentum across most regions in the second half of the financial year, however earnings for the full year will be down on last year, primarily due to the divestment of the South American businesses, lower earnings in the first half and reduced earnings in Europe.”

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Nufarm share price charges higher on FY 2020 guidance appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3lFIZdt

  • 3 reasons why people with disposable income should be investing monthly

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Nationwide shutdowns because of COVID-19, coupled with a slower-than-expected reopening of the economy, have left many people spending more time at home. This global pandemic has hurt so many people financially, but a number of fortunate workers have had no changes to their income.

    If you are one of the latter, you may have seen a decrease in your monthly expenses and an increase in your bank balance. Here are three reasons why you should invest that extra monthly money. 

    The markets are volatile

    Volatility in the stock market has created a unique investment opportunity to use a dollar-cost averaging strategy. With dollar-cost averaging, you budget a certain amount of money each week or month, then use that money to buy shares of stocks or funds. From one month to the next, you get different prices for the securities you buy – some lower, some higher. 

    If you’re left frozen by indecision, or waiting until the stock market bottoms out to take action, this method can really help you. No one really knows when a bottom will happen, and trying to time the market can prove difficult and costly.

    If you invested $10,000 in an S&P 500 index fund at the beginning of 1980 and stayed completely invested throughout the end of 2018, you would have almost $660,000. If you tried to time the markets, failed, and missed out on the top 10 days of market gains, you would only have $318,000. Assuming that you’re already saving money, investing it monthly will help you to avoid this pitfall, taking the guesswork out of trying to time the bottom of the stock market. It will also ensure that your money is always invested, preventing you from missing out on potential gains. 

    It doesn’t take a ton of money

    In my work as a financial advisor, I met many clients who didn’t invest because they never felt as if they had enough money to start. Instead of investing small amounts when they could, they attempted to save lump sums of money – leading to them to miss out on months of market gains, or give up on their investing goals completely.

    Contrary to this belief, you don’t have to be rich or have a ton of money to invest. How long you invest for can be just as important as how much you invest. Consider the following two scenarios:

    Age When You Start Investing

    How Much You Invest Annually

    Number of Years

    Annual Return Earned

    Final Amount

    25

    $1,200

    35

    10%

    $357,752.17

    35

    $2,500

    25

    10%

    $270,454.41

    If you invest less than half as much annually, but start 10 years sooner, you’ll earn roughly 32% more by the time you reach age 60. 

    There’s no time like the present. Using the money you’re saving each month will allow you to get an early start to investing if you’re new to it. If you’re currently investing, this strategy will enable you to save and invest more money than you were before – getting you closer to meeting your financial goals. 

    You’ll get better at planning to invest

    Saving and investing money monthly is extremely important, but finding the extra money to do so isn’t always easy. If you’re currently spending less on leisure activities, now is a perfect time to adjust your priorities and reallocate that money toward investments.

    Start by making a plan. According to a 2019 Modern Wealth Survey by Charles Schwab, having a plan leads to more regular saving. Of the people surveyed, 74% who have a financial plan invest money automatically, compared with just 25% of those who don’t.

    To create a plan, make a list of your monthly expenses before and after the impact of COVID-19. You can shift some of the money that you’re currently saving on leisure activities like dining out or travel toward monthly investments instead. Once the pandemic ends and life as normal resumes, you can continue to enjoy these activities – you’ll just be doing so within your new budget. 

    Once you have a plan in place, it’s a straightforward and easy process. The same way that you can set up a bill to be paid each and every month, you can have money directed monthly to your investment accounts. After the money arrives, you can set up automatic orders to buy your favorite stocks, ETFs, or mutual funds. 

    Once you create these habits, you’ll improve them over time. When you receive pay raises, you can put a portion of them toward investing, rather than entirely increasing your expenses that are within your control. You can also continue to reduce discretionary expenses so that you can save and invest more.

    Uncertainty and turmoil in the world has upended our lives and made everything more difficult, but as Albert Einstein said, “In the middle of difficulty lies opportunity.” Finding and benefiting from these opportunities will help you reach your long-term goals. And taking these few steps now with your disposable income while you have the ability to do so will create long-lasting saving and investing habits that will stay with you long after this pandemic is done. 

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    The Motley Fool has a disclosure policy.

    The post 3 reasons why people with disposable income should be investing monthly appeared first on Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from Motley Fool Australia https://ift.tt/3bpjFDR

  • This is the one investment Warren Buffett says almost everyone should make

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    woman sitting at desk looking at calculator

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    It’s not surprising that many investors watch eagerly for news of Warren Buffett’s stock trades. The Oracle of Omaha has made a successful career (and lots of money) picking stocks. 

    But while there’s a lot you can learn from Buffett, investing like him may not be the best move. His investing goals, his portfolio, and the size of his pocketbook are likely quite different from yours. Instead of emulating his trades, you may be better off listening to his advice — and in particular, the guidance about which investment he believes most people should own. 

    What investment does Buffett recommend for most investors?

    Buffett’s advice for the average investor is simple and easy to follow: Invest in an S&P 500 index fund. 

    Index funds track the performance of market benchmarks. The S&P 500 index Buffett recommends specifically attempts to mimic the performance of 500 large-cap U.S. stocks that, together, account for 80% of all U.S. market capitalization. 

    To be included in the S&P 500, companies must meet certain criteria, including having positive reported earnings for a certain number of quarters and having a reasonable price per share. The index is also weighted by market capitalization, which means each company’s representation is proportional to the total value of all of its outstanding shares. 

    When you invest in the S&P 500, you’re making a bet on large American companies that have a proven track record. In fact, when you buy an S&P 500 index fund, you’ll take a tiny ownership stake in companies you’re almost assuredly familiar with, including Amazon.com Inc (NASDAQ: AMZN), Apple Inc (NASDAQ: AAPL), Clorox, Coca-Cola Co (NYSE: KO), Johnson & Johnson (NYSE: JNJ), JPMorgan Chase, and Ralph Lauren

    Why does Buffett recommend investors buy the S&P 500 index fund?

    As you may be able to guess from the list above, the S&P 500 gives you exposure to businesses across different industries, including tech companies, retailers, and those selling consumer goods. And that’s great news, because when you buy into an S&P index fund, you’re pretty much instantly diversified. 

    Diversification isn’t the only benefit, though. Your returns will parallel the performance of the index, which — between 1926 and 2018 — provided average annual returns of around 10%. It’s very difficult for the typical investor to consistently beat that performance over a sustained period. 

    Investors trying to time the market can also get themselves into trouble, but putting your money into an S&P 500 fund all but eliminates the risk of buying high and selling low (at least for those who leave their money alone for the long term). In fact, anyone who has ever put their money into an S&P 500 index fund and left it alone for at least 20 years would’ve ended up profiting even if they bought in when stocks were at their most expensive. And S&P 500 index funds don’t require active management since they simply include the stocks that make up the index, so they come with few fees that eat away at investment returns. 

    In sum, you don’t have to time the market, you don’t have to consistently pick winning stocks, and you don’t have to worry about paying high fees if you buy an S&P 500 index fund. It’s a simple, easy way to bet big on America and maximize the chance of earning a generous return while minimizing risk, so it’s no wonder Buffett thinks it’s the best bet for most people who don’t spend their entire careers evaluating investments. 

    And while Buffett and other disciplined investors can definitely do better picking individual stocks than investing in an S&P index fund, you need to really be willing to put in the work to do that. Unless you’re committed to developing a sound investment strategy and becoming an expert in the industries you invest in, taking Buffett’s advice and putting your money into this safe, simple investment for the long run may be the best financial move you’ll make. 

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Legendary stock picker names 5 cheap stocks to buy right now

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon five stocks he believes could be some of the greatest discoveries of his investing career.

    These little-known ASX stocks are growing like gangbusters, yet you can buy them today for less than $5 a share. Click here to learn more.

    See these 5 cheap stocks

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Amazon and Apple. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Johnson & Johnson and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool Australia has recommended Amazon and Apple. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post This is the one investment Warren Buffett says almost everyone should make appeared first on Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from Motley Fool Australia https://ift.tt/3jAQlwX